Viewing a single comment thread. View all comments

propargyl t1_ivsykig wrote on November 10, 2022 at 11:32 AM

Reply to comment by TehOwn in New antibiotic passes through the first phase of clinical trials with ease by tonymmorley

https://www.nature.com/articles/s41467-022-29234-3

'A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens.' This drug was designed and tested to demonstrate it is effective against multidrug resistant pathogens.